Fiche publication
Date publication
mai 2018
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier
Tous les auteurs :
Peiffert D, Coche-Dequéant B, Lapeyre M, Renard S
Lien Pubmed
Résumé
The main indications of the brachytherapy of head and neck cancers are the limited tumours of the lip, the nose, the oral cavity and the oropharynx. Nasopharynx tumours are nowadays treated by intensity-modulated radiotherapy. This technique can be exclusive, associated with external radiotherapy or postoperative. It can also be a salvage treatment for the second primaries in previously irradiated areas. If the low dose rate brachytherapy rules remain the reference, the pulse dose rate technique allows the prescription of the dose rate and the optimisation of the dose distribution. Results of high dose rate brachytherapy are now published. This paper reports the recommendations of the Gec-ESTRO, published in 2017, and takes into account the data of the historical low dose rate series, and is upgraded with the pulsed-dose rate and high dose rate series.
Mots clés
Brachytherapy, Cancer, Cancers, Curiethérapie, Débit pulsé, HDD, Haut débit, Head and neck, High dose rate, Low dose rate, PDR, Pulse dose rate, Radiotherapy, Radiothérapie, Tête et cou
Référence
Cancer Radiother. 2018 May 29;:
